In its latest Health Pulse report, Weber Shandwick surveyed synthetic audiences and pharma and biotech communications leaders ...

The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The ...

RSV treatments may be in trouble; Lilly’s dealmaker outlines plans for GLP-1 money; Pfizer’s latest obesity pill bid.

Work culture and overall compensation remain important career components for medical marketers, even as average salaries ...

Experts said the lawsuits and wage garnishments violated community health centers’ mission to make preventive health care ...

Plans with high deductibles — the amount that patients must pay for most medical care before insurance starts pitching in — ...

Regeneron released new early data on two of its blood cancer drugs at ASH, aiming to expand treatment options for patients ...

The plans, which have become common over the past two decades, are getting renewed attention thanks to President Donald Trump ...

Supreme Group has launched Supreme Communications, a full-service PR and communications agency, by combining subsidiary agencies Amendola Communications and Health+Commerce. The 2025 MM+M Agency 100 ...

Structure Therapeutics' obesity drug rivals Lilly and Novo; Mirum Pharma buys Blue Jay Therapeutics; Scientists oppose FDA new CDER acting director.

A North Carolina hospital was slated to open in 2025. Mired in bureaucracy, it’s still a dirt field. For the past three years, Mission Hospital’s owner has contested Florida-headquartered AdventHealth ...

Insulet has appointed Cristal Downing as chief corporate affairs officer, effective Monday, December 8. Downing will report to Ashley McEvoy, president and CEO at Insulet, a medical device company ...